A nurse is caring for a client with a severe traumatic brain injury who has been experiencing increased intracranial pressure (ICP). The client's ICP monitor shows readings consistently above 20 mmHg, and the physician has ordered mannitol 1 g/kg IV. Which nursing action should the nurse prioritize when administering this medication?

Monitoring urine output and fluid balance is critical when administering mannitol to prevent dehydration and electrolyte imbalances from its osmotic diuretic effect. Other actions like rapid administration, glucose checks, or Trendelenburg positioning are not priorities or contraindicated.

Understanding the Medication: Mannitol's Mechanism
When a client has a severe traumatic brain injury, increased intracranial pressure (ICP) — here noted as consistently above 20 mmHg — is a life-threatening emergency. The physician has ordered mannitol, a potent osmotic diuretic. To understand the priority nursing action, you must first understand how mannitol works. As an osmotically active agent, mannitol is administered intravenously and remains within the intravascular space. It creates an osmotic gradient that draws fluid from the brain's interstitial and intracellular spaces back into the bloodstream, thereby rapidly reducing cerebral edema and ICP ^[1]. This fluid is then transported to the kidneys for excretion. In the kidneys, mannitol is freely filtered at the glomerulus but is not reabsorbed by the renal tubules. It exerts an osmotic force within the tubular lumen, preventing water reabsorption and causing a profound osmotic diuresis ^[1]. This dual action—fluid shift from the brain followed by rapid renal elimination—is the core of its therapeutic effect and the source of the most critical nursing considerations.

Why Option 1 is the Priority Nursing Action
The correct answer is to monitor urine output closely and ensure adequate fluid balance. The rationale is directly tied to mannitol's mechanism and its primary safety risks. The powerful osmotic diuresis induced by mannitol can lead to massive fluid loss, risking hypovolemia, hypotension, and pre-renal azotemia if fluid balance is not meticulously managed ^[1]. Furthermore, the loss of free water without a proportional loss of sodium can cause hypernatremia ^[1]. A case-based review of a traumatic brain injury patient specifically illustrates this complex cascade, detailing a clinical course that progressed through a phase of mannitol-induced osmotic diuresis followed by arginine vasopressin deficiency (central diabetes insipidus), highlighting the extreme challenge of managing sodium and fluid balance in this population ^[2]. Therefore, the nurse's immediate priority is to ensure the client does not become volume-depleted, which would compromise cerebral perfusion pressure and overall hemodynamic stability. This involves accurate measurement of urine output, typically via an indwelling urinary catheter, and vigilant monitoring of intake and output, serum electrolytes, and vital signs to guide fluid replacement therapy.

Why the Other Options are Incorrect or Lower Priority

Option 2: Administer the medication rapidly over 5 minutes for maximum effectiveness. This is incorrect and dangerous. While mannitol is used for acute ICP reduction, it is not administered as a rapid IV bolus over 5 minutes in this context. The standard practice for ICP management is to administer the dose as an IV infusion over 15 to 30 minutes. Rapid administration can paradoxically cause vasodilation and a transient increase in ICP, and it increases the risk of hypotension from the sudden osmotic fluid shift ^[1].

Option 3: Check blood glucose levels before and after administration. This is not a priority nursing action specific to mannitol. Mannitol is a sugar alcohol, not glucose, and its administration does not directly cause hypo- or hyperglycemia that requires routine monitoring. While blood glucose control is important in neurocritical care, it is not a direct monitoring parameter for mannitol therapy. The primary metabolic concerns are related to fluid and electrolyte shifts, specifically hypernatremia and a hyperosmolar state ^[1].

Option 4: Position the client in Trendelenburg position during infusion. This is contraindicated. The Trendelenburg position (head lower than feet) would increase intrathoracic and intracranial pressure, directly opposing the therapeutic goal of lowering ICP. The standard of care for a client with elevated ICP is to maintain head-of-bed elevation of at least 30 degrees to promote venous outflow from the brain and optimize cerebral perfusion. This positioning is a fundamental nursing intervention for ICP management, and Trendelenburg would be harmful.

Clinical Integration and Safety
The use of mannitol requires a careful risk-benefit analysis. While it is effective for emergent ICP reduction, its use is limited by a "ceiling effect" and safety concerns, particularly nephrotoxicity and the electrolyte disturbances described ^[1]. A systematic review on alternative osmotic therapies for acute brain injury notes that conventional osmotic agents like mannitol are foundational but highlights the ongoing search for treatments with better safety profiles, underscoring the clinical significance of the complications you are monitoring for . Your focused assessment on urine output and fluid status is the most direct way to detect the earliest signs of these adverse effects and prevent secondary brain injury from hypovolemia or severe electrolyte imbalances.